Interview | WAMJ UPDATE | Page 16 of 24

Dialogue on the Global Health Disparities: WKMO Annual Forum 2016

World Korean Medical Organization Annual Forum 2016 The 2016 Annual WKMO Forum was held in Washington, D.C. on June 9-10th at the Rayburn...

Korea Rise: New Strategies Transforming Korean Biopharma Landscape

Korea Rising BY ERIN MCCALLISTER, SENIOR EDITOR The Korean biopharma industry is mainly known for biosimilars and me-too products. But a...

ISSUE 10

FROM THE PUBLISHER Dear Colleagues, In this issue of WKMJ, we interview Dr. Kyung Sun, a renowned cardiovascular surgeon and the current...

Issue9

March 2016 - April 2016 F.D.A. Toughens Warning Labels for Some Opioid Painkillers The Food and Drug Administration is now requiring new...

Charles Cho, MD, Han Choi, MD, LLM, and Doug Yoon, MD, PhD, MPH, MBA

Charles Cho, MD Managing Director, Palo Alto investors Clinical Professor, Neurology & Neurological Sciences, Stanford Medicine Charles...

Changing the Channel, Overcoming Crisis : Reproducibility Initiatives

--Strategy-- CHANGING THE CHANNEL By Mark Zipkin, Staff Writer Having helped expose the reproducibility crisis about five years ago,...

Early CAR-T Multiple Myeloma Data Promising, Though Efficacy, Safety Remain Unclear

• Source of anti-CD19 CAR-Ts’ benefit obscure • Targeting multiple antigens may be necessary, says expert • Cytokine release...

Samsung RA Biosimilar EU Uptake Tied to Perceived Cost Despite Physician Concerns

• Reference companies may lower drug prices too • Payers may mandate biosimilar use in tender markets • Immunogenicity reactions...

Issue9

North America The Society for Healthcare Epidemiology of America (SHEA) Spring Conference 2016— Science Guiding Prevention May 18-21,...

Key Trends in U.S. Biopharma/Meditech Investing

The 5th New York Health Forum Date: March 31st, 2016 | Venue: The Yale Club of New York City | Time: 1 pm to 5 pm The 5th New York Health...

Subscribe to Our Journal